EpiVax Therapeutics, Inc.
www.epivaxtx.comEpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host. EVT’s pipeline includes a COVID-19 vaccine and a personalized bladder cancer vaccine.
Read more
EpiVax Therapeutics ("EVT"), founded in 2017, employs a world-leading technology, developed over 22 years by EpiVax, to design vaccines that aim to activate the body’s T cells to cure or prevent disease in the host. EVT’s pipeline includes a COVID-19 vaccine and a personalized bladder cancer vaccine.
Read more
Country
State
Rhode Island
City (Headquarters)
Providence
Industry
Employees
1-10
Founded
2017
Social
Employees statistics
View all employeesPotential Decision Makers
Vice President of Research
Email ****** @****.comPhone (***) ****-****Chief Executive Officer
Email ****** @****.comPhone (***) ****-****Chief Technology Officer
Email ****** @****.comPhone (***) ****-****Epivax Therapeutics , Inc.
Email ****** @****.comPhone (***) ****-****
Technologies
(8)
Reach decision makers at EpiVax Therapeutics, Inc.
Free credits every month!
EpiVax Therapeutics, Inc. FAQ
Providence, United States
Biotechnology Research
